Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: I've noticed that some posters are asking

Why would TPL want to buy out PTSC when they are expanding their own product/license range? As it stands, they receive 50% of all licensing revenue collected by Alliasence and do not have to find $1billion-plus for a possible buy out. That type of money is better invested in expanding their own business, in my humble opinion.

http://www.tplgroup.net/products/index.php

 

 

 

Be well

Share
New Message
Please login to post a reply